Top compounds associated with response to RP11-1012A1.4

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	tanespimycin:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.042	0.3
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.038	0.3
mRNA	Vandetanib	CTRPv2	pan-cancer	AAC	0.04	0.3
mRNA	Gefitinib	CTRPv2	pan-cancer	AAC	0.039	0.3
mRNA	VER-155008	CTRPv2	pan-cancer	AAC	-0.04	0.4
mRNA	lomeguatrib	CTRPv2	pan-cancer	AAC	-0.04	0.4
mRNA	BRD-K28456706	CTRPv2	pan-cancer	AAC	-0.04	0.4
mRNA	canertinib	CTRPv2	pan-cancer	AAC	0.039	0.4
mRNA	BRD-K01737880	CTRPv2	pan-cancer	AAC	-0.12	0.4
mRNA	Sildenafil	CTRPv2	pan-cancer	AAC	0.041	0.4

Download CSV